Taevas
ThailandPharmaceuticals
Product Registration
Market Access for Product-Registration in Thailand
Navigating the intricate landscape of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative products achieve timely and successful market entry across diverse
Market
Global
Industry
Product-Registration
Regulator
International Regulatory Bodies
Timeline
6-12 weeks (Strategy Phase)
Deliverables
Market Access Strategy, Regulatory Roadmaps, HTA Reports
What We Deliver
6 Pillars of Market Access
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence
Understanding the nuances of international regulatory requirements is paramount. We provide deep insights into the specific guidelines, submission processes, and compliance standards across key global markets.
Comprehensive Regulatory Landscape Analysis
Pre-Submission Advisory & Gap Analysis
How It Works
How It Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
We begin with an in-depth assessment of your product, target markets, and existing data. This includes a thorough analysis of the global regulatory and market access landscape relevant to your therapeutic area.
Market Snapshot
Market Overview: Global + Product-Registration
Increasing Regulatory Complexity
The global regulatory environment is continuously evolving, with new guidelines and requirements emerging across different regions. Navigating these complexities demands specialized expertise to avoid delays and ensure compliance.
Value-Based Healthcare Imperative
Payers globally are increasingly demanding robust evidence of a product's value beyond clinical efficacy, including economic and real-world outcomes. This shifts the focus towards comprehensive HTA and strong value propositions.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining the recommended market access pathways, key challenges, and strategic recommendations for your target global markets.
Regulatory & HTA Roadmap
A detailed plan mapping out the submission requirements, timelines, and evidence generation strategies for product registration and HTA in selected regions.
Payer & Stakeholder Engagement Plan
A strategic framework for identifying and engaging critical stakeholders, including payers, KOLs, and regulatory authorities, to build support for your product.
Pricing & Reimbursement Analysis
An analysis of potential pricing strategies and reimbursement landscapes across target markets, including competitive benchmarking and risk assessment.
Who This Is For
Use Cases
Biotech Startup
First Global Launch for Novel Oncology Drug
A biotech firm developed a breakthrough oncology treatment but lacked the internal expertise to navigate diverse global regulatory and market access requirements for its first international launch. Taevas provided end-to-end strategic guidance.
Outcome
Achieved registration and market access in three key European markets and Japan within 18 months, exceeding initial timeline expectations.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform your global product registration challenges into market access triumphs. Our expertise ensures your innovations reach patients worldwide efficiently and effectively.
Expedite Global Regulatory Approvals
Optimize Value Proposition for Payers
Navigate Complex International Markets
Maximize Commercial Potential & Patient Reach